Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 73,468 | 70,008 | 62,465 | 59,867 | 67,771 |
| Cost of Goods | 8,177 | 7,115 | 8,574 | 5,552 | 6,035 |
| Gross Profit | 65,291 | 62,893 | 53,891 | 54,315 | 61,736 |
| Operating Expenses | 35,546 | 42,696 | 30,511 | 40,633 | 49,988 |
| Operating Income | 29,745 | 20,197 | 23,380 | 13,682 | 11,748 |
| Interest Expense | 1,099 | 1,117 | 1,067 | 1,146 | 1,208 |
| Other Income | 3,316 | 3,076 | 2,036 | -11,363 | 4,267 |
| Pre-tax Income | 31,962 | 22,156 | 24,349 | 1,173 | 14,807 |
| Income Tax | 411 | 643 | 1,005 | -256 | 457 |
| Net Income Continuous | 31,551 | 21,513 | 23,344 | 1,429 | 14,350 |
| Net Income | $31,551 | $21,513 | $23,344 | $1,429 | $14,350 |
| EBITDA(a) | $37,926 | $28,137 | $30,272 | $7,181 | $20,908 |